Repurposing FDA-Approved Drugs as Hendra Virus RNA-Dependent RNA Polymerase Inhibitors: A Comprehensive Computational Drug Discovery Approach

Enregistré dans:

Détails bibliographiques
Publié dans:	Viruses vol. 17, no. 12 (2025), p. 1613-1633
Auteur principal:	Lalu, Anjana C
Autres auteurs:	Kundil, Varun Thachan, Joseph Bristow Ben, Dev Radul R., Amritha, Thaikkad, Subair Suhail, Raju Rajesh, Abhithaj, Jayanandan
Publié:	MDPI AG
Sujets:	Food & Drug Administration > FDA Australia Physiology RNA polymerase RNA-directed RNA polymerase Toxicity Binding sites Hydrogen Drug development Computer applications DNA-directed RNA polymerase Antiviral agents Bioavailability Proteins Crystal structure Simulation Fatalities RNA viruses Pharmacokinetics FDA approval Pamidronic acid Conserved sequence Bisphosphonates Ligands Viruses Homology
Accès en ligne:	Citation/Abstract Full Text + Graphics Full Text - PDF
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!